Invesco Ltd. - RAPT THERAPEUTICS INC ownership

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 100 filers reported holding RAPT THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.4%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of RAPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$419,704
+61.1%
25,253
+81.2%
0.00%
Q2 2023$260,603
-6.1%
13,936
-7.9%
0.00%
Q1 2023$277,526
-92.6%
15,124
-90.2%
0.00%
-100.0%
Q3 2022$3,728,000
+1683.7%
154,934
+1526.9%
0.00%
Q1 2022$209,000
-39.9%
9,523
+0.6%
0.00%
Q4 2021$348,000
-80.8%
9,470
-83.8%
0.00%
Q3 2021$1,811,000
+633.2%
58,304
+649.0%
0.00%
Q2 2021$247,0007,7840.00%
Other shareholders
RAPT THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Column Group LLC 2,680,621$44,551,92129.58%
GREAT POINT PARTNERS LLC 1,458,070$24,233,1234.41%
Euclidean Capital LLC 1,315,798$21,868,5622.39%
Trustees of Columbia University in the City of New York 73,383$1,219,6252.24%
KINGDON CAPITAL MANAGEMENT, L.L.C. 805,828$13,392,8611.54%
Perceptive Advisors 1,920,658$31,921,3361.06%
Deep Track Capital, LP 1,500,000$24,930,0000.96%
Cheyne Capital Management (UK) LLP 20,000$332,4000.96%
Alphabet Inc. 540,270$8,979,2870.58%
BRAIDWELL LP 1,082,512$17,991,3490.57%
View complete list of RAPT THERAPEUTICS INC shareholders